Wellcome support for open access

British charity wants a system of open and unrestricted access for research it funds

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Britain's Wellcome Trust has thrown its support behind open-access publishing of scientific research, after a report it commissioned came to the conclusion that the publishing status quo does not operate in the interests of scientists or the public.

The trust, which plans to distribute more than £400 million (approximately $662 million) in funding to biomedical sciences in the year 2003–2004, commissioned economic development consultants SQW to undertake a thorough investigation into the £22 billion (approximately $36 billion) scientific publishing industry.

What it found was a clash of priorities among those involved—commercial publishers who want to better their business position, libraries who struggle to buy journals on tight budgets, and researchers who want their research published in reputable journals.

"The current market structure does not operate in the long-term interests of the research community," the report says.

Mark Walport, director of the Wellcome Trust, said his organization is committed to ensuring ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo